BioHarvest Sciences Inc.

News Release--> Tate & Lyle Expands Collaboration with BioHarvest Tate & Lyle and BioHarvest are expanding their sweetener molecule development program to include multiple next‑generation, plant‑based sweetener molecules. “Broadening the development program demonstrates confidence in the versatility of our Botanical Synthesis™ platform and in the progress delivered through our collaboration with Tate & Lyle. Together, we are enabling access to differentiated, plant‑based sweetening solutions designed to support a range of sensory, application and economic requirements.” ---Zaki Rakib, BioHarvest CEO Read Full New Release: ir.bioharvest.com/news/default.a… This collaboration reinforces Tate & Lyle's long‑term strategy: driving growth through differentiated innovation and advancing the future of sweetness.

Q1 Earnings Conference Call to be held May 14, 8am ET. Join Webcast: events.q4inc.com/attendee/38718…

News Release-->BioHarvest Sciences Reports First Quarter 2026 Financial Results Read Full Release: ir.bioharvest.com/news/default.a…

News Release--> BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications. CDMO program now advances to Stage 2 of ongoing development agreement. Read Full Release: ir.bioharvest.com/news/default.a…

News Release--> BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using its Proprietary Botanical Synthesis Platform. View news release: ir.bioharvest.com/news/default.a… The source plant is widely regarded as one of the most valuable fragrance raw materials in the world.

News Release--> BioHarvest Sciences to Report First Quarter 2026 Financial Results May 14, 2026. Q1 Earnings conference call and webcast will start at 8:00 a.m. ET May 14 to discuss the results and provide an update on business operations. All interested investors and media are invited to join live webcast and Q+A. Register for webcast: events.q4inc.com/attendee/38718…

$BHST News Release-->BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate “Two-Lens” Growth Strategy. Ilan Sobel appointed to Board of Directors. Read Full News Release: bit.ly/4cHK8xU

As reported in our FY 2025 Earnings Call - VINIA is now the # 1 Resveratrol brand in the USA, based on NielsonIQ and Amazon.com data and projections for 2025 Resveratrol Nutritional Supplements and Beverages. Go VINIA!!

News Release--> BioHarvest Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform. -->CDMO division has successfully completed Stage 1 under a development contract Read Full News Release: bit.ly/3PGtrK2

BioHarvest Q4 and Full Year 2025 Earnings Call is today, Tuesday, March 31, 2026, at 4:30 PM ET. The webcast will feature the full analyst Q+A, and is open to all investors. Join us! Webcast link: events.q4inc.com/attendee/51206…

News Release--> BioHarvest Sciences Announces that VINIA is now the No.1 Resveratrol Polyphenol Brand in the United States. Read news release: bit.ly/4bJok2Z “Achieving the No.1 position in the U.S. resveratrol category in less than five years reflects both the strength of VINIA and the power of our Botanical Synthesis platform technology,” said Ilan Sobel, CEO.

VINIA BloodFlow Hydration is a hit at the 38th Annual Roth Investor Conference - "Crush Your Meetings Today" is what everyone is aiming to do. We are hosting in the Concierge room all day Tuesday- come and connect if you are at the event!

Last Chance! Registration for the VINIA Blood Flow Hydration Challenge ends tonight! Get ready to hydrate smarter, move daily, and feel the VINIA difference. Join thousands committing to better hydration, circulation, and daily energy — together. This isn’t just hydration. It’s a movement. Want to learn more? Visit vinia.com/pages/hydratio…, and then join the ZOOM Kickoff party tonight, March 17, at 8pm ET: us02web.zoom.us

News Release--> BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results, provide an update on business operations, and host an analyst Q+A. Read release: bit.ly/4uApPZQ Register for webcast: bit.ly/4lvCut0

1 Day until kickoff! Register NOW for the VINIA Hydration Challenge! Chances to win daily prizes, Weekly prizes, and amazing grand prizes. Register here: vinia.com/pages/hydratio… Participate for all 30 days, share your journey with your online Instagram and Facebook videos and posts and support others in their Blood Flow Hydration Challenge. Get ready to discover your true potential. HYDRATE MORE, MOVE YOUR BODY, TRACK IT, POST IT and MOTIVATE OTHERS to live their best lives! #VINIAHydrationChallenge #VINIABloodFlow

BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026. CEO Ilan Sobel will attend and host 1x1 investor meetings throughout the event. Read March 3, 2026 news release: bit.ly/4r7dn0K

Roth Capital initiates Analyst coverage of BioHarvest Sciences (BHST) investing.com/news/analyst-r…

CEO Ilan Sobel discussing cholesterol with Dave Asprey, the "Father of Biohacking": facebook.com/reel/154746354…

News Release--> BioHarvest Issues Year End CEO Shareholder Letter. "2025 marked an important milestone for BioHarvest Sciences: our first full year as a NASDAQ-listed company, and we enter 2026 with an annualized revenue run rate exceeding US$36 million and gross margins above 60%..." Read full letter: bioharvest.com/bioharvest-sci…